Study Summary
This trial will test if a passive ROM exercise program can improve the movement of infants with HLHS and other single right ventricle anomalies following the Norwood procedure.
- Congenital Heart Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 4 months of age or superior cavopulmonary connection (SCPC) evaluation clinic visit, whichever comes first
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Standard of care
1 of 2
Passive range-of-motion
1 of 2
Active Control
Experimental Treatment
238 Total Participants · 2 Treatment Groups
Primary Treatment: passive range of motion exercise therapy · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age < 18 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
How often do patients report negative side effects from passive range of motion exercise therapy?
"There is available clinical evidence supporting the safety of passive range of motion exercise therapy, so it received a score of 3." - Anonymous Online Contributor
Would it be easy for me to find a clinical trial location near me?
"The primary locations for this trial are Boston Children's Hospital, Children's Healthcare of Atlanta / Emory University, and Texas Children's Hospital / Baylor. Additionally, there are 10 other places where this trial is taking place." - Anonymous Online Contributor